Stephen C. Glover has an estimated net worth of $40.3 Million. This is based on reported shares across multiple companies, which include ANDRX CORP /DE/, INSMED Inc, PDS Biotechnology Corp, Ambrx Biopharma Inc., ZyVersa Therapeutics, Inc., AURIGA LABORATORIES, INC., and Ambrx Biopharma, Inc..

2022 was Stephen C. Glover's most active year for acquiring shares with 15 total transactions. Stephen C. Glover's most active month to acquire stocks was the month of November. 2024 was Stephen C. Glover's most active year for disposing of shares, totalling 4 transactions. Stephen C. Glover's most active month to dispose stocks was the month of February. 2021 saw Stephen C. Glover paying a total of $49,997.00 for 14,882 shares, this is the most they've acquired in one year. In 2009 Stephen C. Glover cashed out on 569,811 shares for a total of $337,430.00, their largest year based on trade value.